T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
AMERISAFE
AMSF
$504M
| $267K | ﹤0.01% |
5,136
-3,394
| -40% | -$165K |
|
|
TDAY
2477
USA Today Co
TDAY
$1B
| $267K | ﹤0.01% |
92,075
+8,369
| +10% | +$31.8K |
|
2478
Tactile Systems Technology
TCMD
$537M
| $267K | ﹤0.01% |
36,616
+6,568
| +22% | +$83.2K |
|
|
TGH
2479
DELISTED
Textainer Group Holdings limited
TGH
| $267K | ﹤0.01% |
9,747
+285
| +3% | +$9.2K |
|
|
AMRS
2480
DELISTED
Amyris Inc.
AMRS
| $267K | ﹤0.01% |
144,297
-28,394
| -16% | -$83.6K |
|
2481
Clear Channel Outdoor Holdings
CCO
$1.18B
| $266K | ﹤0.01% |
249,033
+52,589
| +27% | +$110K |
|
2482
Daily Journal
DJCO
$828M
| $265K | ﹤0.01% |
1,025
-166
| -14% | -$44.7K |
|
2483
Sylvamo
SLVM
$1.55B
| $265K | ﹤0.01% |
8,111
-957
| -11% | -$40.1K |
|
2484
Transmedics
TMDX
$3.11B
| $265K | ﹤0.01% |
8,421
+171
| +2% | +$4.56K |
|
2485
Arcturus Therapeutics
ARCT
$223M
| $263K | ﹤0.01% |
16,732
+410
| +3% | +$8.05K |
|
2486
Stagwell
STGW
$2.28B
| $263K | ﹤0.01% |
48,351
+1,941
| +4% | +$13.7K |
|
2487
Universal Technical Institute
UTI
$1.42B
| $263K | ﹤0.01% |
36,890
+3,090
| +9% | +$27.2K |
|
|
NGM
2488
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $262K | ﹤0.01% |
20,440
+1,425
| +7% | +$19.7K |
|
|
CTO
2489
CTO Realty Growth
CTO
$823M
| $261K | ﹤0.01% |
12,828
+120
| +0.9% | +$2.52K |
|
2490
Clean Energy Fuels
CLNE
$395M
| $260K | ﹤0.01% |
58,077
+2,274
| +4% | +$13.2K |
|
2491
Varex Imaging
VREX
$780M
| $260K | ﹤0.01% |
12,177
+302
| +3% | +$6.42K |
|
|
CDR
2492
DELISTED
Cedar Realty Trust, Inc
CDR
| $260K | ﹤0.01% |
9,020
-476,751
| -98% | -$13M |
|
2493
Matrix Service
MTRX
$328M
| $259K | ﹤0.01% |
51,100
+4,625
| +10% | +$29K |
|
2494
PC Connection
CNXN
$2.04B
| $258K | ﹤0.01% |
5,861
+105
| +2% | +$4.98K |
|
|
BCLI
2495
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $257K | ﹤0.01% |
6,200
| – | – |
|
|
XXII
2496
22nd Century Group
XXII
$1.42M
| – | – |
0
| – | – |
|
2497
Seaboard Corp
SEB
$4.08B
| $256K | ﹤0.01% |
66
+1
| +2% | +$4.03K |
|
2498
Super Micro Computer
SMCI
$25.3B
| $256K | ﹤0.01% |
63,460
+3,750
| +6% | +$17.1K |
|
2499
Accuray
ARAY
$32.9M
| $255K | ﹤0.01% |
129,994
-7,964
| -6% | -$19.9K |
|
2500
BCE
BCE
$21.7B
| $255K | ﹤0.01% |
5,200
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.